Abstract
This study aimed to establish and characterize primary cell cultures and xenografts derived from penile carcinoma (PeCa) in order to provide experimental models for cellular processes and efficacy of new treatments. A verrucous squamous cell carcinoma (VSCC) was macrodissected, dissociated, and cultivated in KSFM/DF12 medium. Cell cultures were evaluated at passage 5 (P5) using migration and invasion assays and were serially propagated, in vivo, in BALB/c nude mice until passage 3 (X1–X3). Immunophenotypic characterization of cultures and xenografts was performed. Genomic (CytoScan HD, Affymetrix) and transcriptomic profiles (HTA 2.0 platform, Affymetrix) for VSCC, cell cultures, and xenografts were assessed. P5 cells were able to migrate, invade the Matrigel, and produce tumors in immunodeficient mice, demonstrating their malignant potential. The xenografts unexpectedly presented a sarcomatoid-like carcinoma phenotype. Genomic analysis revealed a high similarity between the VSCC and tumor-derived xenograft, confirming its xenograft origin. Interestingly, a subpopulation of P5 cells presented stem cell-related markers (CD44+CD24− and ALDH1high) and sphere-forming capacity, suggesting their potential xenograft origin. Cell cultures and xenografts retained the genomic alterations present in the parental tumor. Compared to VSCC, differentially expressed transcripts detected in all experimental conditions were associated with cellular morphology, movement, and metabolism and organization pathways. Malignant cell cultures and xenografts derived from a verrucous penile carcinoma were established and fully characterized. Nevertheless, xenograft PeCa models must be used with caution, taking into consideration the selection of specific cell populations and anatomical sites for cell/tumor implantation.
Similar content being viewed by others
References
Chaux A, Lezcano C, Cubilla AL, Tamboli P, Ro J, Ayala A. Comparison of subtypes of penile squamous cell carcinoma from high and low incidence geographical regions. Int J Surg Pathol. 2010;18:268–77.
Chaux A, Cubilla AL. Advances in the pathology of penile carcinomas. Hum Pathol. 2012;43:771–89.
Wollina U, Steinbach F, Verma S, Tchernev G. Penile tumours: a review. J Eur Acad Dermatol Venereol. 2014;28:1267–76.
Chaux A, Reuter V, Lezcano C, Velazquez EF, Torres J, Cubilla AL. Comparison of morphologic features and outcome of resected recurrent and nonrecurrent squamous cell carcinoma of the penis: a study of 81 cases. Am J Surg Pathol. 2009;33:1299–306.
Louzada S, Adega F, Chaves R. Defining the sister rat mammary tumor cell lines HH-16 cl.2/1 and HH-16.cl.4 as an in vitro cell model for Erbb2. PLoS One. 2012;7:e29923.
Reyal F, Guyader C, Decraene C, Lucchesi C, Auger N, Assayag F, et al. Molecular profiling of patient-derived breast cancer xenografts. Breast Cancer Res. 2012;14:R11.
Sausville EA, Burger AM. Contributions of human tumor xenografts to anticancer drug development. Cancer Res. 2006;66:3351–4.
He Q, Wang X, Zhang X, Han H, Han B, Xu J, et al. A tissue-engineered subcutaneous pancreatic cancer model for antitumor drug evaluation. Int J Nanomed. 2013;8:1167–76.
Hiroshima Y, Zhang Y, Zhang N, Maawy A, Mii S, Yamamoto M, et al. Establishment of a patient-derived orthotopic Xenograft (PDOX) model of HER-2-positive cervical cancer expressing the clinical metastatic pattern. PLoS One. 2015;10:e0117417.
Ishikawa S, Kanoh S, Nemoto S. Establishment of a cell line (TSUS-1) derived from a human squamous cell carcinoma of penis. Hinyokika Kiyo. 1983;29:373–6.
Tsukamoto T. Establishment and characterization of a cell line (KU-8) from squamous cell carcinoma of the penis. Keio J Med. 1989;38:277–93.
Gentile G, Giraldo G, Stabile M, Beth-Giraldo E, Lonardo F, Kyalwazi SK, et al. Cytogenetic study of a cell line of human penile cancer. Ann Genet. 1987;30:164–9.
Naumann CM, Sperveslage J, Hamann MF, Leuschner I, Weder L, Al-Najar AA, et al. Establishment and characterization of primary cell lines of squamous cell carcinoma of the penis and its metastasis. J Urol. 2012;187:2236–42.
Afonso LA, Moyses N, Alves G, Ornellas AA, Passos MR, Oliveira Ldo H, et al. Prevalence of human papillomavirus and Epstein-Barr virus DNA in penile cancer cases from Brazil. Mem Inst Oswaldo Cruz. 2012;107:18–23.
Sobin LH, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours (UICC International Union Against Cancer). 7th ed. Chicester: Wiley-Blackwell; 2009.
Remmele W, Stegner HE. Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe. 1987;8:13840.
Dobner BC, Riechardt AI, Joussen AM, Englert S, Bechrakis NE. Expression of haematogenous and lymphogenous chemokine receptors and their ligands on uveal melanoma in association with liver metastasis. Acta Ophthalmol. 2012;90:e638–44.
Wei JH, Cao JZ, Zhang D, Liao B, Zhong WM, Lu J, et al. EIF5A2 predicts outcome in localized invasive bladder cancer and promotes bladder cancer cell aggressiveness in vitro and in vivo. Br J Cancer. 2014;110:1767–77.
Turin I, Schiavo R, Maestri M, Luinetti O, Dal Bello B, Paulli M, et al. In vitro efficient expansion of tumor cells deriving from different types of human tumor samples. Med Sci. 2014;2:70–81.
Croce MV, Colussi AG, Segal-Eiras A. Assessment of methods for primary tissue culture of human breast epithelia. J Exp Clin Cancer Res. 1998;17:19–26.
Bonner-Weir S, Taneja M, Weir GC, Tatarkiewicz K, Song KH, Sharma A, et al. In vitro cultivation of human islets from expanded ductal tissue. Proc Natl Acad Sci U S A. 2000;97:7999–8004.
Cree IA, Glaysher S, Harvey AL. Efficacy of anti-cancer agents in cell lines versus human primary tumour tissue. Curr Opin Pharmacol. 2010;10:375–9.
Quante M, Tu SP, Tomita H, Gonda T, Wang SS, Takashi S, et al. Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth. Cancer Cell. 2011;19:257–72.
Visvader JE, Lindeman GJ. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer. 2008;8:755–68.
Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A. 2003;100:3983–8.
Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 2005;65:10946–51.
Cox CV, Evely RS, Oakhill A, Pamphilon DH, Goulden NJ, Blair A. Characterization of acute lymphoblastic leukemia progenitor cells. Blood. 2004;104:2919–25.
Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell. 2007;1:555–67.
Clay MR, Tabor M, Owen JH, Carey TE, Bradford CR, Wolf GT, et al. Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase. Head Neck. 2010;32:1195–201.
Kuasne H, Cólus IM, Busso AF, Hernandez-Vargas H, Barros-Filho MC, Marchi FA, et al. Genome-wide methylation and transcriptome analysis in penile carcinoma: uncovering new molecular markers. Clin Epigenetics. 2015;7:46.
Aparicio S, Hidalgo M, Kung AL. Examining the utility of patient-derived xenograft mouse models. Nat Rev Cancer. 2015;15:311–6.
EI-Awady RA, Hersi F, AI-Tunaiji H, Saleh EM, Abdel-Wahab AH, AI Homssi A, et al. Epigenetics and miRNA as predictive markers and targets for lung cancer chemotherapy. Cancer Biol Ther. 2015;16:1056–70.
Zheng Q, Ye J, Cao J. Translational regulator eIF2α in tumor. Tumour Biol. 2014;35:6255–64.
Xiang M, Namani A, Wu S, Wang X. Nrf2: bane or blessing in cancer? J Cancer Res Clin Oncol. 2014;140:1251–9.
Halliwell B. Oxidative stress in cell culture: an under-appreciated problem? FEBS Lett. 2003;540:3–6.
Rotblat B, Melino G, Knight RA. NRF2 and p53: Januses in cancer? Oncotarget. 2012;3:1272–83.
Acknowledgments
The authors are grateful for the assistance given by MSc. Rainer Marco Lopes Lapa and Dr Vilma R Martins for the scientific support with the xenograft model.
Funding
This study was supported by grants from the National Council of Technological and Scientific Development (CNPq 573589/08-9) and São Paulo Research Foundation (FAPESP 2009/52088-3, 2010/51601-6, and 2009/14027-2).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflicts of interest
None
Additional information
Juan J. Muñoz and Sandra A. Drigo contributed equally to this work.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Fig. S1
Schematic flow chart of the study design including the establishment and characterization of verrucous penile carcinoma cell cultures and xenografts. IHC: immunohistochemistry; P1-P5: cell culture passage from first to fifth (in vitro), X1, X2 and X3: xenograft in the first, second and third passages (in vivo). Immunophenotyping of xenograft cell cultures (X1, X2 and X3) was done (rectangle with dashed lines). (TIF 945 kb)
Table S1
Antibodies used for phenotypic characterization assays. (DOC 41 kb)
Table S2
Phenotypic characterization of cell cultures and xenografts. (DOC 39 kb)
Table S3
Genomic alterations detected in cell cultures (P1 and P5) and xenograft on passage 1 (X1) in comparison with the parental penile carcinoma (VSCC). (DOC 106 kb)
Table S4
Top 20 differentially expressed genes detected in cell cultures (P1 and P5) and xenografts (X1-X3) in comparison with the parental penile carcinoma (VSCC). (DOC 54 kb)
Rights and permissions
About this article
Cite this article
Muñoz, J.J., Drigo, S.A., Kuasne, H. et al. A comprehensive characterization of cell cultures and xenografts derived from a human verrucous penile carcinoma. Tumor Biol. 37, 11375–11384 (2016). https://doi.org/10.1007/s13277-016-4951-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13277-016-4951-z